Safety of Propofol Sedation ( > 200 mg) for Colonoscopy.

Showa Inan General Hospital

Status: Completed

Conditions: Safety Issues

Treatments: Drug: Propofol

Study type: Observational

Funder types: Other

Identifiers

NCT05213208

PS>200

Details and patient eligibility

About

This study examines that the use of >200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.

Full description

The hospital policy of routine discharge to normal activity 1 hour after propofol mono-sedation for EGD or colonoscopy was approved by the ethics committee of Showa Inan General Hospital in January, 2004 (http://www.sihp.jp). The investigator' s subsequent experience verified the safety of this discharge policy which was reconfirmed in March 2014. Based on these studies, the upper limit of 200 mg was established for those allowed early discharge and driving to home.

This study examines that the use of >200 mg of propofol sedation enables patients to drive home safely 90-120 minutes after outpatient colonoscopy.

Enrollment: 300 patients

Sex: All

Ages: 20 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• subjects who drive home by theirselves after colonoscopy using propofol sedation (>200 mg)

Exclusion criteria

• Subjects who received emergency procedures
• less than 20 years old pregnant American Society of Anesthesiologists (ASA) class III or IV, overweight (body weight >100 kg) allergic to the drugs used or its components (soybeans or eggs).